Literature DB >> 25770680

Homo- and hetero-dimerization of human UDP-glucuronosyltransferase 2B7 (UGT2B7) wild type and its allelic variants affect zidovudine glucuronidation activity.

Lingmin Yuan1, Sainan Qian1, Yongsheng Xiao1, Hongying Sun1, Su Zeng2.   

Abstract

Most human UDP-glucuronosyltransferase (UGT; EC 2.4.1.17) genes contain non-synonymous single nucleotide polymorphisms (nsSNPs) which cause amino acid substitutions. Allelic variants caused by nsSNPs may exhibit absent or reduced enzyme activity. UGT2B7 is one of the most important UGTs that glucuronidates abundant endobiotics and xenobiotics, such as estriol, morphine, and anticancer drugs. Three nsSNPs, UGT2B7*71S (211G>T), UGT2B7*2 (802C>T) and UGT2B7*5 (1192G>A) are observed in the UGT2B7 gene, and they code for allozymes UGT2B7*71S (A71S), UGT2B7*2 (H268Y), and UGT2B7*5 (D398N). UGT2B7 has been observed to form oligomers that affect its enzymatic activity and in this study, we investigated protein-protein interactions among UGT2B7 allozymes wild type (WT), A71S, H268Y and D398N, by performing a systematic quantitative fluorescence resonance energy transfer (FRET) analysis in combination with co-immunoprecipitation assay. Quantitative FRET analysis revealed that UGT2B7 allozymes formed homo- and hetero-dimers and showed distinct features in donor-acceptor distances. Both codon 71 and codon 268 in the N-terminal domain were involved in the dimeric interaction. Co-immunoprecipitation experiments also proved that UGT2B7 allozymes formed stable dimers. The glucuronidation activities of homo- and hetero-dimers were further tested with zidovudine as the substrate. An increase in activity was observed when WT hetero-dimerized with A71S compared with homo-dimers, while both H268Y and D398N impaired the activity of WT and A71S by forming hetero-dimers. In addition, zidovudine glucuronidation activity is associated with FRET distance. These findings provide insights into the consequences of amino acid substitution in UGT2B7 on zidovudine glucuronidation and the association between protein-protein interaction and glucuronidation activity.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dimerization; FRET; UGT2B7; Uridine 5-diphosphoglucuronic acid (PubChem CID: 17473); Zidovudine; Zidovudine (PubChem CID: 35370); Zidovudine O-glucuronide (PubChem CID: 105108); nsSNPs

Mesh:

Substances:

Year:  2015        PMID: 25770680     DOI: 10.1016/j.bcp.2015.03.002

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variants.

Authors:  Zi-Zhao Yang; Li Li; Lu Wang; Ling-Min Yuan; Ming-Cheng Xu; Jing-Kai Gu; Hui-di Jiang; Lu-Shan Yu; Su Zeng
Journal:  Acta Pharmacol Sin       Date:  2017-05-29       Impact factor: 6.150

2.  The Human UGT2B7 Nanodisc.

Authors:  Ian Cook; Anna B Asenjo; Hernando Sosa; Thomas S Leyh
Journal:  Drug Metab Dispos       Date:  2019-12-31       Impact factor: 3.922

3.  Inter-isoform Hetero-dimerization of Human UDP-Glucuronosyltransferases (UGTs) 1A1, 1A9, and 2B7 and Impacts on Glucuronidation Activity.

Authors:  Ling-Min Yuan; Zhang-Zhao Gao; Hong-Ying Sun; Sai-Nan Qian; Yong-Sheng Xiao; Lian-Li Sun; Su Zeng
Journal:  Sci Rep       Date:  2016-11-18       Impact factor: 4.379

Review 4.  Structure and Protein-Protein Interactions of Human UDP-Glucuronosyltransferases.

Authors:  Ryoichi Fujiwara; Tsuyoshi Yokoi; Miki Nakajima
Journal:  Front Pharmacol       Date:  2016-10-24       Impact factor: 5.810

Review 5.  Advances in the Understanding of Protein-Protein Interactions in Drug Metabolizing Enzymes through the Use of Biophysical Techniques.

Authors:  Jed N Lampe
Journal:  Front Pharmacol       Date:  2017-08-08       Impact factor: 5.810

6.  Brain-derived neurotrophic factor involved epigenetic repression of UGT2B7 in colorectal carcinoma: A mechanism to alter morphine glucuronidation in tumor.

Authors:  Zi-Zhao Yang; Li Li; Ming-Cheng Xu; Hai-Xing Ju; Miao Hao; Jing-Kai Gu; Zai-Jie Jim Wang; Hui-Di Jiang; Lu-Shan Yu; Su Zeng
Journal:  Oncotarget       Date:  2017-04-25

7.  Integrate thermostabilized fusion protein apocytochrome b 562 RIL and N-glycosylation mutations: A novel approach to heterologous expression of human UDP-glucuronosyltransferase (UGT) 2B7.

Authors:  Jia Xue; Haitao Zhang; Su Zeng
Journal:  Front Pharmacol       Date:  2022-08-12       Impact factor: 5.988

8.  Dimerization of human uridine diphosphate glucuronosyltransferase allozymes 1A1 and 1A9 alters their quercetin glucuronidation activities.

Authors:  Yan-Qing Liu; Ling-Min Yuan; Zhang-Zhao Gao; Yong-Sheng Xiao; Hong-Ying Sun; Lu-Shan Yu; Su Zeng
Journal:  Sci Rep       Date:  2016-03-30       Impact factor: 4.379

9.  Human variability in isoform-specific UDP-glucuronosyltransferases: markers of acute and chronic exposure, polymorphisms and uncertainty factors.

Authors:  E E J Kasteel; K Darney; N I Kramer; J L C M Dorne; L S Lautz
Journal:  Arch Toxicol       Date:  2020-05-15       Impact factor: 5.153

10.  Effects of CYP3A5 and UGT2B7 variants on steady-state carbamazepine concentrations in Chinese epileptic patients.

Authors:  Qiong Lu; Yuan-Tao Huang; Yi Shu; Ping Xu; Da-Xiong Xiang; Qiang Qu; Jian Qu
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.